FDA Drug Approvals
Printable Version   Email to a friend

FDA Approves Glumetza

FDA Approves Glumetza for Type 2 Diabetes

Glumetza is a once-daily, extended-release formulation of metformin hydrochloride which may offer potential advantages such as less frequent dosing and fewer side effects. Glumetza is indicated for the treatment of Type 2 diabetes.

Related Articles:

Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza - January 2, 2008

Depomed, Biovail Update Status of Glumetza NDA - April 13, 2005

Biovail, Depomed Receive Approvable Letter from FDA for Extended-Release Glumetza for Type II Diabetes - March 1, 2005

Biovail, Depomed Announce Glumetza NDA Accepted by FDA - June 24, 2004

Biovail and Depomed Submit NDA for Glumetza; Submission Includes 500mg and 1000mg dosages; Biovail/Depomed Expand Royalty Agreement to Include 1000mg dose - April 28, 2004

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources


MedNotes
Advertisement